Markets:

Overview

News

Currencies

International

Treasuries

AtaiBeckley Inc. - Common Stock (NQ:ATAI)

4.005 -0.135 (-3.26%)

Streaming Delayed Price Updated: 2:16 PM EDT, Mar 11, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about AtaiBeckley Inc. - Common Stock

< Previous 1 2

...

5 6 7 8 9 10 11 12 13

...

29 30 Next >

3 Penny Stocks to Make You the Millionaire Next Door ↗

May 25, 2023

Explore the world of high-risk, high-reward top penny stocks to buy and uncover promising investment opportunities.

Via InvestorPlace

Psyched: $20M Research Fund, LSD Microdosing For Cancer, MEAI Enters Clinical Stage, Reform Update & More ↗

May 15, 2023

Researchers At Johns Hopkins Get $20M Fund Prompted By Longtime Psychedelics Scientist Johns Hopkins University academics received a boost in funding thanks to the recently launched Roland R. Griffiths...

Via Benzinga

Atai Life Sciences Q1 2023 Results, Pipeline Update On DMT And Psilocybin Clinical Trials ↗

May 11, 2023

Clinical-stage biopharma company atai Life Sciences (NASDAQ: ATAI) reported the financial results for its first quarter ended March 31, 2023, and provided the period’s business highlights. Consolidated...

Via Benzinga

atai Life Sciences Reports First Quarter 2023 Financial Results and Announces Pipeline Highlights and Updates

May 11, 2023

From atai Life Sciences

Via GlobeNewswire

atai Life Sciences to Participate in Upcoming May Investor Conference

May 02, 2023

From atai Life Sciences

Via GlobeNewswire

April Psychedelic Drug Stocks Recap: The Ups And Downs ↗

April 30, 2023

Via Talk Markets

atai Life Sciences Presents Pharmacodynamic Data on GRX-917 in a Late Breaking Poster Presentation at the 2023 SOBP Annual Meeting

April 28, 2023

From atai Life Sciences

Via GlobeNewswire

Seelos Therapeutics, Compass Pathways Among Top Psychedelic Movers Of Today ↗

April 21, 2023

Via Benzinga

Invitae, CSX And Other Big Stocks Moving Higher In Friday's Pre-Market Session ↗

April 21, 2023

U.S. stock futures traded mixed this morning. Here are some big stocks recording gained in today’s pre-market trading session. Mullen Automotive, Inc. (NASDAQ: MULN) shares jumped 30.2% to $0.1103 in...

Via Benzinga

Seelos Therapeutics, ATAI Life Sciences Among Top Psychedelic Movers Of Today ↗

April 20, 2023

Via Benzinga

After Falling 60% in 1 Year, Is Atai Life Sciences Stock Still a Buy? ↗

April 20, 2023

Atai's stock is hurting, but its pipeline is still packed with promising programs.

Via The Motley Fool

Cybin, Mind Medicine Among Top Psychedelic Movers Of Today ↗

April 19, 2023

Via Benzinga

Psychedelic Stock Gainers And Losers From April 18, 2023 ↗

April 18, 2023

Via Benzinga

Psychedelic Stock Gainers And Losers From April 17, 2023 ↗

April 17, 2023

Via Benzinga

Psyched: Clinical-Grade MDMA, LSD For Depression, Partnerships For Delivering Psychedelic Therapies & More ↗

April 17, 2023

Revolutionizing Psychedelics: 2 Industry Leaders Team Up On Clinical-Grade MDMA Capsules

Via Benzinga

Atai Advances R-Ketamine Through Phase 1 Bridging Study, Update And Near-Term Expectations ↗

April 14, 2023

Clinical-stage biopharma company atai Life Sciences (NASDAQ: ATAI) announced the dosing of the first subject in majority-owned subsidiary Perception Neuroscience’s Phase 1 intravenous-to-subcutaneous

Via Benzinga

ATAI Life Sciences, Seelos Therapeutics Among Top Psychedelic Movers Of Today ↗

April 14, 2023

Via Benzinga

Psychedelic Stock Gainers And Losers From April 13, 2023 ↗

April 13, 2023

Via Benzinga

atai Life Sciences Announces First Subject Dosed in the Phase 1 IV-to-Subcutaneous Bridging Study of PCN-101 (R-Ketamine)

April 13, 2023

From atai Life Sciences

Via GlobeNewswire

Psychedelic Stock Gainers And Losers From April 12, 2023 ↗

April 12, 2023

Via Benzinga

Psychedelic Stock Gainers And Losers From April 11, 2023 ↗

April 11, 2023

Via Benzinga

Psyched: MDMA Therapy Advances With FDA, Alternatives For Alcohol Addiction, Prince Harry In The Spotlight And More ↗

April 11, 2023

MDMA Therapy For PTSD Nearing Legalization In U.S. And Worldwide, MAPS Releases Promising Data

Via Benzinga

Psychedelic Stock Gainers And Losers From April 10, 2023 ↗

April 10, 2023

Via Benzinga

Psychedelic Stock Gainers And Losers From April 7, 2023 ↗

April 07, 2023

Via Benzinga

Psychedelic Stock Gainers And Losers From April 6, 2023 ↗

April 06, 2023

Via Benzinga

Compass Pathways, GH Research Among Top Psychedelic Movers Of Today ↗

April 05, 2023

Via Benzinga

"Rags-To-Riches" Portfolio Down 8.6% In March; Now -3.9% YTD ↗

April 05, 2023

The

Via Talk Markets

Psychedelic Stock Gainers And Losers From April 4, 2023 ↗

April 04, 2023

Via Benzinga

Butterfly Network, APE Preferred Shares And Other Big Stocks Moving Higher In Tuesday's Pre-Market Session ↗

April 04, 2023

U.S. stock futures traded higher this morning. Here are some big stocks recording gains in today’s pre-market trading session.

Via Benzinga

Seelos Therapeutics, ATAI Life Sciences Among Top Psychedelic Movers Of Today ↗

April 03, 2023

Via Benzinga

< Previous 1 2

...

5 6 7 8 9 10 11 12 13

...

29 30 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.